↓ Skip to main content

Dove Medical Press

Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity

Overview of attention for article published in OncoTargets and therapy, March 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
7 Mendeley